|2nd October 2020||Kerrii B Anderson||11.34||Grant/award etc.||$688.84||$7,811.45|
|25th September 2020||Brian J Caveney||289||Payment by withholding||$180.99||$52,306.11|
|25th September 2020||Brian J Caveney||970||Exercise of derivative||$0.00|
|23rd September 2020||Kerrii B Anderson||3,500||Grant/award etc.||$0.00|
|27th August 2020||Richelle P Parham||7,474||Grant/award etc.||$0.00|
|10th August 2020||Glenn A Eisenberg||6,800||Grant/award etc.||$0.00|
|7th August 2020||R Sanders Williams||250||Open or private sale||$242.95||$60,737.50|
|8th July 2020||R Sanders Williams||1,300||Exercise of derivative||$98.49||$128,037.00|
|8th July 2020||R Sanders Williams||1,300||Open or private sale||$173.12||$225,056.00|
|6th July 2020||Kerrii B Anderson||13.28||Grant/award etc.||$588.25||$7,811.96|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.
Laboratory Corp. of America Holdings is a clinical laboratory company. The company engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments.